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I
ncorporation of Uaas into proteins using a host’s endogenous
translation machinery opens the door to addressing questions
with chemical precision that is unattainable using naturally
occurring amino acids. This expanded toolset allows one to pose
and answer more in-depth molecular questions without the
limitations imposed by the 20 natural amino acids used in
traditional mutagenic analyses.
1,2 Aminoacyl-tRNA synthetases
(RSs) obtained by structure-based engineering and directed
evolution eﬃciently recognize and activate Uaas through ATP-
dependent adenylation and subsequently catalyze transfer to
their cognate tRNA. To date, more than 70 Uaas are now
amenable to translational insertion into proteins in bacteria,
yeast, or mammalian cells using these artiﬁcially evolved tRNA/
RS pairs.
3 By choosing particular matching sets of tRNA/RSs
from diverse organisms, the pairs can function in vivo in an
orthogonal manner. In other words, there is limited if any
crosstalk between the expression host’s native tRNA/RS pairs
and the orthogonal tRNA/RS pair; however, the orthogonal pair
is still able to functionally couple with the host’s protein
translational machinery. The tRNA
Tyr/TyrRS pair derived from
the archaeon Methanocaldococcus jannaschii was the ﬁrst success-
fulpairtodirectthegeneticallyencodedincorporationoftheUaa
O-methyl-L-tyrosine (Ome) into translated proteins in vivo.
4,5
Thisinitialresultthenspawnedtheincorporationofthemajority
of Tyr-based Uaas possessing distinct functional groups into
recombinant proteins. Recently, another matching set, namely,
the tRNA
Pyl/PylRS pair, was used to incorporate Uaas bearing
functional groups similar to Pyl.
6 12
In most cases regarding tRNA
Tyr/TyrRS systems, sterically
innocuous modiﬁcations of the phenyl ring, typically focused on
the para position, are employed as unnatural substrates. Simi-
larly, most Uaas incorporated by the tRNA
Pyl/PylRS pair all
contain slight variations of the extended Pyl side chain, while the
core Lys moiety and the N
ε-carbonyl group of Pyl remain
unchanged.
3 In short, most evolved orthogonal tRNA/RS pairs
demonstrate speciﬁcity for Uaas that maintain the chemical core
of the native amino acid substrate, thus limiting the stereochem-
ical diversity of Uaas accessible to the researcher. Since the RS
component of the pair plays a key role in amino acid substrate
selection, it is of tremendous importance to probe the extent to
which it can be engineered not only to activate a chemically and
structurally divergent amino acid but also its ability to transfer
thisnewaminoacidtoitscognatetRNA.Giventhatthedegreeof
substrate speciﬁcity exhibited byan RS is functionally coupled to
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ABSTRACT: Unnatural amino acids (Uaas) can be transla-
tionally incorporated into proteins in vivo using evolved tRNA/
aminoacyl-tRNA synthetase (RS) pairs, aﬀording chemistries
inaccessible when restricted to the 20 natural amino acids. To
date,mostevolvedRSsaminoacylate Uaaschemicallysimilarto
the native substrate of the wild-type RS; these conservative
changes limit the scope of Uaa applications. Here, we adapt
Methanosarcina mazei PylRS to charge a noticeably disparate
Uaa, O-methyl-L-tyrosine (Ome). In addition, the 1.75 Å X-ray
crystalstructureoftheevolvedPylRScomplexedwithOmeand
a non-hydrolyzable ATP analogue reveals the stereochemical
determinantsforsubstrateselection.Catalyticallysynergisticactivesitemutationsremodelthesubstrate-binding cavity,providing a
shortened but wider active site. In particular, mutation of Asn346, a residue critical for speciﬁc selection and turnover of the Pyl
chemical core, accommodates diﬀerent side chains while the central role of Asn346 in aminoacylation is rescued through
compensatory hydrogen bonding provided by A302T. This multifaceted analysis provides a new starting point for engineering
PylRS to aminoacylate a signiﬁcantly more diverse selection of Uaas than previously anticipated.734 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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the accuracy of protein translation, the RS is restrained by
tremendous selective pressure; therefore, integration of structur-
al approaches with directed evolution of RSs can expand upon
ourunderstandingoftheevolutionarytenetsgoverningsubstrate
speciﬁcity and selection.
13 15 This uniﬁed approach applied in
the form of multiple rounds of structure-based design and dire-
cted evolution can often produce RSs with altered speciﬁcity for
Uaa substrates in relatively rapid fashion.
Moreover, the inability to eﬃciently employ mammalian cells
and multicellular organisms for evolving tRNA/RS pairs further
limits the scope of unnatural substrates available for probing
in vivo protein function in organisms more complex than micro-
bial hosts. Currently, directed approaches for evolving a Uaa-
speciﬁc RS involve the generation of an initial RS mutant library
minimally containing 10
8 to 10
9 members.
1,4 These numbers,
coupled with the need for eﬃcient selection procedures, limit
applicability to organisms possessing high transformation eﬃ-
ciency and favorable growth characteristics.
1 The approach was
ﬁrstdevelopedinE.coli
4,16andlaterexpandedtoincludeanother
unicellular organism, Saccharomyces cerevisiae.
17,18 Nevertheless,
maintenance of large mutant libraries and selection methods are
diﬃcult to implement in more complex systems such as mam-
malian cells and multicellular organisms.
One solution is to evolve an RS that possess characteristics
favorable to deployment in the intended mammalian hosts in
recombinant organisms such as E. coli or yeast. Assuming the
appropriate RS is chosen, the evolved RSs shouldthen be readily
integrated into mammalian cells or a multicellular organism for
further optimization once the large collection of mutants is
narrowed substantially. This divide and conquer approach thus
shortcuts some of the anticipated problems faced during the
initial rounds of selection.
19 This kind of strategy was applied
to the tRNA
Tyr/TyrRS pair from E. coli, wherein the TyrRS
was ﬁrst evolved in yeast and then transferred to mammalian
cell hosts.
19,20 Nonetheless, most reported mutant RSs evolved
in yeast generally lack the in vivo eﬃciency of the original
M. jannaschii TyrRS evolved and exploited in E. coli. Moreover,
M.jannaschiiTyrRSdoesnotoperateinanorthogonalmannerin
mammalian cells, often cross-charging mammalian tRNAs.
Withtheselimitationsinmind,tRNA
Pyl/PylRSisanattractive
alternative because of the demonstrated orthogonal behavior of
this particular pair in E. coli and mammalian cells.
9,10,21,22 Muta-
ting the active site does not impact orthogonality so the evolved
pairs are highly unlikely to cross-react with the endogenous
tRNA/RS pairs of their mammalian hosts. One remaining issue,
however, concerns the extent to which the current assortment
of orthogonal pairs can be evolved to speciﬁcally adenylate and
then charge their cognate tRNAs with substrates substantially
diﬀerent from their natural substrates. Strikingly, to date, Uaas
incorporated by mutant RSs derived from PylRS bear close
chemical and steric resemblance to the natural Pyl substrate.
3
High ﬁdelity Uaa incorporation is essential for generating
chemically homogeneous proteins for investigation. An opti-
mally evolved RS should function similarly to a wild-type RS,
which achieves high incorporation ﬁdelity under physiological
growth conditions and maintains ﬁdelity when cells are grown in
nutrient-rich media. For Uaa incorporation in E. coli, nutrient-
rich media is necessary to ensure high in vivo incorporation
eﬃciency of the evolved RS; however, when an evolved RS
possesses non-optimal speciﬁcity for the Uaa, minimal media
lacking certain or all natural amino acids must be used to limit the
mis-incorporation of any natural amino acids into the recombinant
protein.
23 Unfortunately, minimal media cannot be applied to
traditional fermentations, mammalian cell cultures, and whole
organism engineering; this drawback prevents the transfer and
usage of non-optimally evolved RSs in these situations. More-
over, the active site of a non-optimal RS must lack the com-
plementarystereochemicalfeaturesforselectionofthegivenUaa
substrate. Structural analyses then become critical for providing
architectural guides to explain and further optimize the substrate
selection and turnover. Recently, Wang et al. reported the
incorporation of two Phe-based Uaas into proteins via evolved
PylRSs,albeitinE.coligrownsolelyinminimalmedia.
24Todate,
eﬃcient evolution of PylRS to speciﬁcally incorporate a Uaa
signiﬁcantly deviating from the native Pyl in rich media followed
by transfer to mammalian hosts has not been demonstrated.
Moreover, the structural transformations that occur in the
active site of such a highly speciﬁc PylRS mutant necessary for
accommodating a dramatic substrate change remain unclear.
Here we show that the Methanosarcina mazei PylRS (MmPylRS)
can be evolved to eﬃciently charge a Uaa with a short aromatic
sidechain,incontrasttothelongaliphaticsidechainofthenative
substrate Pyl.TheevolvedRSincorporatestheUaaintoproteins
with high ﬁdelity in both E. coli grown in rich media and mam-
maliancells.Additionally, wesolvedandreﬁnedtheX-raycrystal
structure of the evolved PylRS complexed with the new Uaa and
an ATP analogue to a nominal resolution of 1.75 Å. The three-
dimensional structure and active site architecture in the trapped
substrate-bound form conﬁrms that the mutations obtained
contribute directly to the high stereochemical selectivity of our
mutant PylRS for turnover of Tyr-based Uaas. Furthermore, this
combined structure function investigation provides the experi-
mental support necessary to continue diversifying and optimiz-
ing PylRS variants in E. coli to further expand the variety of
smaller Uaas for later use in mammalian cells.
’RESULTS AND DISCUSSION
LaboratoryEvolutionoftheMethanosarcinamazeitRNACUA
Pyl /
PylRS pair. To expand the amino acid repertoire available to
the orthogonal tRNACUA
Pyl /PylRS pair, we employed MmPylRS
as a model for rationally engineering high specificity toward Tyr-
basedUaaanalogues.OnthebasisoftheX-raycrystalstructureof
wild-type MmPylRS,
25 six residues (Ala302, Leu309, Asn346,
Cys348, Val401, and Trp417) lining the active site cavity were
chosen for mutational expansion to create a genetically diverse
PylRS library (Figure 1b). The Y384F mutation of PylRS,
previously shown to increase the aminoacylation rate,
26 was used
as the starting PylRS sequence and remained fixed in our
population of mutants. In general, RS engineering and directed
evolution has subtly reshaped RS amino acid specificity by
limiting mutagenic exploration to amino acid positions that
encompass a portion of the extended amino acid side chain.
Accordingly, mutant RS libraries generated from TyrRS and
PylRS have restricted genetic diversity to deep within the amino
acid binding pocket.
1,3,4,10 To accommodate the dramatic sub-
strate switch from the long aliphatic Pyl tail to a short aromatic
moiety,wemutatedactivesiteresiduesliningtheentiresurfaceof
the side chain binding pocket in theY384F PylRS mutant library.
Inparticular,Asn346,proposedtoserveasa“gatekeeper”forPyl
binding,
25,27 has until now been retained and not subjected to
mutational expansion in most reported PylRS libraries. We,
by contrast, specifically targeted this residue for mutational735 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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expansion to drive substrate selectivity substantially away from
the natural Pyl substrate.
Our mutant library contains approximately 10
9 mutational
variants,assessedbycountingcolony-formingunitsaftereﬃcient
E. coli transformation. Cells were then subjected to positive
selection in the presence of 1 mM of Ome (Figure 1a). Survival
relies on the suppression of an amber stop codonintroducedat a
permissive site in the chloramphenicol acetyltransferase gene
upongrowthinthepresenceof30μgmL
 1chloramphenicol.
4,16
Y384F PylRS mutant variants able to charge the orthogonal
tRNACUA
Pyl with either natural or the added Uaa should then
suppress the amber codon, lead to chloramphenicol acetyltrans-
ferase expression, and aﬀord chloramphenicol resistance to the
host E. coli strain.
A total of 48 colonies survived on agar plates containing
30 μgm L
 1 chloramphenicol and 1 mM Ome. A secondary
screen to further narrow mutant selection employed a quantita-
tiveassessmentofthegrowthoftheoriginal48colonieson1mM
Ome using a matrix of chloramphenicol concentrations. One
mutant, named MmOmeRS, aﬀorded an IC50 of 15 μgm L
 1
chloramphenicol in the absence of Ome and 80 μgm L
 1
chloramphenicol in the presence of Ome. Sequencing revealed
that the MmOmeRS gene contained the ﬁxed mutation Y384F
and four additional changes, A302T, N346V, C348W, and V401L.
MmOmeRS Specifically Incorporates the Selected Uaa in
E.coli.Tomeasuretheinvivotranslationefficiencyandfidelityof
MmOmeRSforincorporationofOmeintorecombinantproteins
in E. coli, the sperm whale myoglobin gene with an amber UAG
codon at position 4 (Myo4TAGHis6) was used together with
the tRNACUA
Pyl /MmOmeRS pair in E. coli strain DH10β under
control of the isopropyl β-D-1-thiogalactopyranoside(IPTG)-
inducible T5 promoter. As shown in Figure 2a, when the
nutrient-rich growth media 2xYT was supplemented with Ome
(1 mM), full-length myoglobin appeared. Recombinant His6-
tagged myoglobin was purified by Ni
2þ affinity chromatography
Figure 1. Evolving M. mazei PylRS to aminoacylate Uaas bearing
aromatic side chains. (a) Structures of pyrrolsyine 1 and O-methyl-L-
tyrosine (Ome, 2). (b) Structure of the active site of M. mazei PylRS
(PDB ID: 2ZCE). Pyl is shown in cyan. The codons of the six residues
highlighted in yellow were diversiﬁed with NNK oligonucleotides by
PCR to generate a mutant library. MmOmeRS was selected from this
library using Uaa Ome.
Figure 2. MmOmeRS speciﬁcally incorporates the cognate Uaa Ome
into proteins in E. coli. (a) Suppression of the amber codon in sperm
whalemyoglobinatposition4byM.janaschiiOmeRS-tRNACUA
Tyr andM.
mazei OmeRS-tRNACUA
Pyl with and without Ome, respectively. Myoglo-
binproteinswerepuriﬁedusingNi-NTAresin,separatedbySDS-PAGE
andstainedwithCommassie.Sampleswerenormalizedforconstantcell
numbers for each lane. (b, c) High resolution FT ion trap MS of the
intact myoglobin protein expressed in the presence of MmOmeRS-
tRNACUA
Pyl supplemented with 1 mM Ome (b) and without Ome in the
growth media (c). Average and monoisotopic (indicated by MI) masses
are labeled. In the absence of Ome, MmOmeRS incorporates Phe and
Trp at low eﬃciencies. In the presence of Ome, only the Uaa was found
tobeincorporatedattheUAG-encodedpositionbyMmOmeRS.Apeak
with monoisotopic mass of 18508.61 was detected corresponding to
myoglobin containing Ome at position 4; oxidation and deamidation
peaks for thisprotein were also detected and labeled. Another peak with
monoisotopic mass of 18377.58 was detected corresponding to Ome-
containing myoglobin lacking the initiating Met; an oxidation for this
species was also detected. (d) MS analysis of GFP expressed in the
presenceofMmOmeRS-tRNACUA
Pyl supplementedwith1mMOme.The
spectrum shows the intact precursor ions (charge deconvoluted) for
one tryptic fragment of GFP (
þH3N-HNIEDGSVQLADHXQQNT-
PIGDGPVLLPDNHYLSTQ SALSK-CO2H, X representing the UAG
encoded site). The labeled peak corresponds to the incorporation of
Ome at the UAG encoded position. Tandem MS spectrum of this
peptide is shown in Supplementary Figure 1, which unambiguously
conﬁrms the peptide sequence and Ome at position X.736 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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followedbygelfiltrationchromatographyto∼98%homogeneity
yielding 4.6 mg L
 1 myoglobin. In the absence of the Uaa, small
amounts (0.68 mg L
 1) of full-length myoglobin appeared,
most likely due to low level charging of natural amino acids to
tRNACUA
Pyl by MmOmeRS. For comparison, the Ome-specific
tRNACUA
Tyr /synthetase pair previously evolved from wild-type
M. jannaschii tRNA
Tyr/TyrRS
4 was used to incorporate Ome
into myoglobin, yielding 3.2 mg L
 1 of recombinant myoglobin
containing Ome.
To measure the ﬁdelity of Uaa incorporation, the puriﬁed
myoglobin was analyzed by electrospray ionization Fourier
transform ion trap mass spectrometry (ESI-FTMS). For myo-
globin obtained with the tRNACUA
Pyl /MmOmeRS strain, a peak
with a monoisotopic mass of 18508.61 Da was observed
(Figure2b).Thismasscorrespondstointactmyoglobincontain-
ing a single Ome residue at position 4 (expected [M þ H]
þ =
18,508.77 Da). A second peak measured corresponds to Ome-
containingmyoglobinlacking theinitiatingMet(expected[M 
Met þ H]
þ = 18377.73 Da, measured 18377.58 Da). Notably,
no peaks corresponding to proteins containing any other amino
acids at the amber codon position were observed. The signal-to-
noise ratio of >1,000 observed in the intact protein mass spectra
translates to a ﬁdelity of >99.9% for the incorporation of Ome
with the tRNACUA
Pyl /MmOmeRS pair. Recombinant myoglobin
produced using thetRNACUA
Pyl /MmOmeRSpair inmedia lacking
Ome was also puriﬁed and analyzed by mass spectrometry
(Figure 2c). The monoisotopic masses obtained indicate that
Phe or Trp were incorporated at the UAG sites (expected
[M(Phe) þ H]
þ = 18477.75 Da, measured 18477.52 Da;
expected [M(Phe)   Met þ H]
þ = 18346.71 Da, measured
18347.44 Da; expected [M(Trp)   Met þ H]
þ = 18385.72 Da,
measured 18385.48 Da). While these proteins contain natural
amino acids, it is notable that the incorporated amino acids are
similar to the Ome Uaa and quite distinct from the cognate Pyl
amino acid of the original wild-type PylRS.
To assess the generality of MmOmeRS, a GFP gene contain-
ing a UAG codon at position 182 was employed. In the absence
and presence of Ome, 0.13 and 13.89 mg L
 1 of GFP were
obtained, respectively. Ome-containing GFP was digested with
trypsin and analyzed by ESI-FTMS. Ions for the tryptic GFP
peptides clearly indicate that Ome was incorporated at the UAG
site (expected [M þ H]
þ = 4486.19 Da, measured 4486.18 Da),
and no peaks corresponding to any other amino acid incorpo-
rated at the UAG site were detected (Figure 2d). The precursor
ion [M þ H]
þ corresponding to the peptide
þH3N-HNIED-
GSVQLADHXQQNTPIGDGPVLLPDNHYLSTQSALSK-CO2
 
(where X represents the UAG site) was also analyzed by tandem
MS, and ion masses unambiguously conﬁrmed the peptide
sequence and assigned Ome to the UAG site (Supplementary
Figure 1). In summary, these experimental observations demon-
stratethatwhileMmOmeRSwillacceptthesterically similarPhe
or Trp natural amino acids at low levels in the absence of Ome,
the tRNACUA
Pyl /MmOmeRS pair speciﬁcally incorporates Ome
with high ﬁdelity and eﬃciency when its cognate amino acid
Ome is present.
Use of MmOmeRS for Uaa Incorporation in Mammalian
Cells. One historical drawback associated with tRNA/RS pairs
evolved in bacteria is that they are generally not orthogonal in
eukaryotic cells and thus cannot be transferred to more complex
systems such as mammalian cells or whole organisms. A sig-
nificant advancement is the ability to evolve pairs in easily
manipulated and efficiently transformed bacterial cells and then
transfer the optimized orthogonal pairs directly to mammalian
cells while preserving efficient and high fidelity Uaa incorpora-
tionintoexpressedproteins.
10,19,20MmOmeRSwastestedforits
ability to incorporate Uaas in HEK293 and HeLa cells. The
tRNACUA
Pyl was expressed under control of the polymerase (Pol)
III H1 promoter with the 30 flanking sequence of the human
tRNA
Tyrappendedtothe30 endofthetRNACUA
Pyl geneforcorrect
30 end processing.
19 MmOmeRS was conditionally expressed
using the mammalian PGK promoter.
19 The GFP gene with a
UAG stop codon introduced at a permissive site Tyr182 was
cotransfected with the tRNACUA
Pyl /MmOmeRS into HEK293
cells. Cells were grown in media with or without the Uaa Ome.
As shown in Figure 3a, green fluorescence appeared when cells
weregrowninthepresenceofOme.IntheabsenceoftheUaa,no
Figure3. MmOmeRSincorporatesthecognateUaaOmeinmammaliancells.(a)FluorescentimagingofHEK293cellstransfectedwithdiﬀerentgenes
as labeled. Cells transfected with the E. coli tRNACUA
Tyr /TyrRS pair, which incorporates Tyr at the UAG codon, were used as a positive control. For cells
transfectedwiththeGFP(182TAG)reportergeneandthetRNACUA
Pyl /MmOmeRSpair,greenGFPﬂuorescencewasdetectedincellsculturedinmedia
containing1mMOme,indicatingthattheUaaisincorporatedintoGFP.NoGFPﬂuorescencewasdetectedincellsculturedinmedialackingOme.(b)
Incorporation eﬃciency of MmOmeRS measured with ﬂow cytometry. The stable HeLa-GFP(182TAG) reporter cell line was transfected with the
tRNACUA
Pyl /MmOmeRS pair and grown in media with and without 1 mMOme. Cellular GFP ﬂuorescence intensities were measured by ﬂow cytometry
and normalized to cells transfected with the E. coli tRNACUA
Tyr /TyrRS pair. Error bars represent standard error of mean (SEM, n = 3).737 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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bright green fluorescent cells were observed. To accurately
quantify the Ome incorporation efficiency, a HeLa cell line with
the GFP(182TAG) gene stably integrated into the chromo-
some
19 was used as a reporter. After transfecting the tRNACUA
Pyl /
MmOmeRS pair, flow cytometry was then used to measure
cellular GFP fluorescence. Total fluorescence intensity was
normalized to the quantified fluorescence of HeLa cells trans-
fected with the E. coli tRNACUA
Tyr /TyrRS pair (Figure 3b). In-
corporation efficiency for the tRNACUA
Pyl /MmOmeRS pairs was
4.54% with a background suppression of 0.09% detected in the
absence of Ome.
A remaining challenge for the incorporation of Uaas into
proteins in mammalian cells is the eﬃcient transcription of an
orthogonal tRNA incapable of being charged by the host’s
endogenous RSs. Previously, we developed a general method
to transcribe bacterial tRNAs in mammalian cells under
control of type-3 Pol III promoters.
19 These promoters, includ-
ing the H1 and U6 promoters, enable the eﬃcient transcribing
of tRNAs that do not possess the consensus A- and B-boxes
normally required for Pol III transcription in mammalian cells.
The M. mazei tRNACUA
Pyl used in this current study comes from
the domain Archaea, and unlike bacterial tRNAs, this archaeal
tRNA contains a consensus eukaryotic B-box and an imperfect
A-box sequences. The M. mazei tRNACUA
Pyl can also be function-
ally expressed under transcriptional control by the H1 promoter
in mammalian cells. The results described here support the
deployment of type-3 Pol III promoters for expressing other
archaeal tRNAs in mammalian cells.
9
Three-Dimensional Architecture of MmOmeRS. Following
structure-guided mutation and selection, MmOmeRS switched
amino acid specificity from the native substrate Pyl to the
structurally divergent substrate Ome. Notably, the new specifi-
city obtained for Ome differs substantially from the wild-type
specificity for the long aliphatic side chain of Pyl. To understand
the molecular basis underlying this evolutionary change, we
determined the high-resolution X-ray crystal structure of the
catalytic domain of MmOmeRS complexed with Ome and the
non-hydrolyzable ATP analogue AMP-PNP.
MmOmeRS, like its wild-type ancestor PylRS, puriﬁed as a
homodimer and crystallized in space group P64 with unit cell
dimensions of a = 104.81 Å, b = 104.81 Å, c = 71.67 Åand angles
R = β =9 0 , γ = 120 using the previously published crystal-
lization conditions for wild-type MmPylRS.
25 MmOmeRS was
also cocrystallized with Mg
2þ, the non-hydrolyzable ATP analo-
gue AMP-PNP, and the Uaa Ome. The crystal structure of the
ternary Ome-AMP-PNP-Mg
2þ complex was solved by molec-
ular replacement and reﬁn e dt o1 . 7 5Åw i t ha nRfactor of 18.3%
and an Rfree of 21.2% (see Table 1 for data processing and
reﬁnement statistics). The SIGMAA weighted 2Fo   Fc experi-
mental electron density maps exhibited clear electron density
f o rO m e ,A M P - P N P ,a n dt w oo c t a h e d r a l l yc o o r d i n a t e dM g
2þ
ions. MmOmeRS crystals contained one ternary complex per
asymmetric unit; two ternary complexes related by a 2-fold
crystallographic symmetry axis form the likely physiological dimer
of MmOmeRS.
PylRS and the MmOmeRS mutant belong to the class-II
division of aminoacyl-tRNA synthetases (PF00587).
25 This fold
consists of a central antiparallel seven-stranded β-sheet deco-
rated by several peripheral helices. The overall tertiary structure
of MmOmeRS (Figure 4a) is consistent with all previously
reported crystal structures for PylRSs, generating root-mean-
squaredeviation(rmsd)valuesrangingfrom0.16to0.23Åupon
superposition of C-R atoms with representative family members
(PDB IDs 2ZCE, 2ZIN, and 2Q7G). Structural alignment of the
MmOmeRSstructurereportedherewiththepreviouslyreported
PylRS structure complexed with AMP-PNP and Pyl (PDB ID:
2ZCE)
27 illustrates conserved AMP-PNP binding with the
sterically and chemically divergent amino acid Ome occupying
a similar active site location as the wild-type cognate amino acid
Pyl.
25 27
One notable structural diﬀerence between the MmOmeRS
crystal structure reported here and other published PylRS
structures encompasses residues across the β7 β8 loop
(Val177 Gly185). Previous crystal structures of wild-type
PylRS establish several distinct conformations of this loop,
including open, intermediate, and closed conformations that
areseeminglyindependentoftheboundPylaminoacidligand.
27
In the crystal structure of MmOmeRS, electron density for the
β7 β8 loop is noticeably absent, signifying that the loop most
likely contributes in a dynamic manner to active site closure and
catalysis.
Table 1. X-ray Diﬀraction Data Processing and Reﬁnement
Statistics
protein MmOmeRS
ligands Ome, AMP-PNP, Mg
2þ
PDB ID 3QTC
Data Collection and Processing
space group P64
resolution (Å) 1.75
cell dimensions
a, b, c (Å) 104.81, 104.81, 71.67
R, β, γ (DEG) 90, 90, 120
molecules in asymmetric unit 1
no. measured reﬂections
a 458839 (45558)
no. unique reﬂections
a 44965 (7161)
redundancy 10.2 (6.4)
Rmerge (%)
a,b 4.0 (36.8)
completeness (%)
a 99.7 (98.9)
I/σ(I)
a 35.1 (4.3)
Reﬁnement
resolution range (Å) 50.0 1.75
no. reﬂections
working set 42693
test set 2268
Rwork/Rfree
c 0.1834/0.2124
no. atoms
protein 2157
ligands 306
water 235
mean overall B-factor (Å
2) 29.93
rmsd bond lengths (Å)
d 0.01
rmsd bond angles (DEG) 1.30
reﬁnement program Refmac
aValues in parentheses represent data from the highest resolution shell.
bRmerge = ΣhklΣi|Ii(hkl)   <I(hkl)>|/Σhkl ΣiIi(hkl)
cRfactor = Σ||Fobs|  
|Fcalc||/Σ|Fobs|. Rwork is the Rfactor calculated using all diﬀraction data
included in the reﬁnement. Rfree is the Rfactor calculated using the
randomly chosen 5% of diﬀraction data that were not included in the
reﬁnement.
drmsd = root-mean-square deviation738 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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ActiveSiteSubstitutionsLeadtoanUnexpectedRecognition
of the Ome Side Chain Moiety. MmOmeRS contains a single
fixedmutation,Y384F,andfouradditionalmutationsselectedfor
duringdirectedevolution:A302T(locatedontheN-terminalend
of the R5 helix), N346V and C348W (abutting residues on the
C-terminal end of the β6 strand), and V401L (located on the
C-terminal end of the β9 strand) (Figure 4b). The methyl group
of Ome is clearly visible on the tip of the bound ligand,
distinguishing Ome from the structurally similar natural amino
acid Tyr (Figure 4c). In all previous studies of PylRS, the wild-
type residue Asn346 serves to (1) directly bind the secondary
carbonyl(N
ε-carbonyl)ofPylorPylanaloguesthroughhydrogen
bonding and (2) coordinate the R-amino group or R-carboxyl
group, depending on the orientation of the main chain atoms in
Pyl or Pyl analogues. This latter interaction occurs through a
water-mediated hydrogen bond (Figure 5b,c).
25 27 Evolved
MmOmeRS possesses a non-hydrogen bond donor acceptor at
position 346 (Figure4b). Curiously,previousresults demonstrate
that mutation of Asn346 to Ala significantly impairs aminoacyla-
tion activity in PylRS,
27 suggesting some form of compensatory
changes in the selected MmOmeRS.
The X-ray crystal structure of the MmOmeRS-Ome-AMP-
PNP-Mg
2þternary complexillustrateshowtheA302T mutation
positions the hydroxyl-bearing Thr side chain as a bump on the
active site surface in proximity to the β-sheet deﬁning the ﬂoor
of the amino acid binding site. On this ﬂoor, the other critical
change, N346V, projects up and into the active site (Figure 4b).
The Thr hydroxyl moiety sterically and electronically compen-
satesfortheloss ofthehydrogenbondcontributedbyAsn346 in
wild-type PylRS. In particular, Thr302 in MmOmeRS assumes
twodistinct rotameric conformations(Figure 4d), both of which
hydrogen bond directly to the R-carboxyl group of Omewithout
the interventionof awater molecule(Figure 5a).In addition, the
N346V mutation abolishes the previously observed hydrogen-
bondinginteractionbetweenAsn346andthesidechaincarbonyl
group of Pyl or Pyl analogues in PylRS.
In wild-type PylRS, Leu305, Tyr306, Cys348, and Trp417
form a deep hydrophobic pocket in the active site that accom-
modates the elongated methyl-pyrroline ring of Pyl. In MmO-
meRS, the C348W mutation places the indole moiety of Trp348
directly into this elongated cavity, thereby shortening the depth
of the cavity (Figure 4b). Consequently, the active site volume
decreases from 2883 to 2174 Å
3 when comparing PylRS (PDB
ID: 2ZCE) to MmOmeRS, respectively. In PylRS, the mutation
C348A does not exert a measurable eﬀect on activity, suggesting
that this residue does not contribute signiﬁcantly to stabilization
of the transition state accompanying amino acid charging.
27 In
contrast, MmOmeRS uses Trp348 to not only facilitate recogni-
tion of Ome but also to stabilize the O-methyl group on Ome
through a quadrupole-dipole interaction that is a direct result
of the indole plane sitting perpendicular to the O-methyl
moietyofOme.Finally,theV401Lmutationextendsthewild-
typeValsidechainbyamethylenegroupallowingtheLeuside
chainmoietytoreachandbetteraccommodatetheshorterbut
wider Ome side chain (Figure 4b). In total, these selected
mutationsinMmOmeRSwidenpartoftheaminoacidbinding
cavity while condensing its depth, ultimately providing a
complementary shape to accommodate the bulky phenyl ring
of Ome.
Recognition of the Ome Main Chain and Coordination
of the Adenyl-Donor AMP-PNP-Mg
2þ. In MmOmeRS, the
R-aminoandR-carboxyl groupsofOmerotatecounterclockwise
103alongtheCR CβbondrelativetotheirpositionsinPylRS;
this rotation effectively flips the positions of the R-amino and
R-carboxyl groupsinOme-bound MmOmeRS compared to Pyl-
boundPylRS.Thisinterchangeresultsindistinctlydifferentstabiliz-
ing interactions (Figure 5a,b). For example, in wild-type PylRS,
the R-aminogroup of Pylinteracts withthe side chainof Asn346
via a water-mediated interaction. In MmOmeRS, the R-amino
group of Ome hydrogen-bonds via a water-mediated interaction
to one of two observed rotameric conformations of Ser399.
Conspicuously, Ser399 resides distal to position 346 along the
surface of the active site cavity. In PylRS, Arg330 interacts
through electrostatic hydrogen bonds with the negatively charged
R-carboxyl group of Pyl; this electrostatic role is replaced by a
neutral hydrogen-bonding network in MmOmeRS triggered by
Figure 4. Crystal structure of MmOmeRS reveals the stereochemical
basis for Ome selectivity. (a) Global view of the crystal structure of
MmOmeRS expressed as a ﬁlled surface. (b) Depiction of the four
mutations deﬁning the transformation of PylRS to MmOmeRS in the
crystalstructureofMmOmeRScomplexedwithOme,Mg
2þ,andAMP-
PNP. Both the Uaa (Ome) and the non-hydrolyzable ATP-analogue
(AMP-PNP)areshowntogetherwiththecalculatedSIGMAA-weighted
2Fo   Fc electron density contoured at 2σ and 2.5σ, respectively. (c)
Comparison of the calculated SIGMAA-weighted 2Fo   Fc electron
density contoured at 2σ for both Ome (left) and a structurally related
amino acid Tyr272 (right) demonstrates that the quality of electron
density is excellent for both protein residues and substrates. Moreover,
theO-methylmoietyisunequivocallypresentinOme.(d)Diﬀerencesin
the shapes ofthe electron density contoured at1.75σ forboththe active
site Thr302 (left) and a second Thr343 (right) support the presence of
two alternate conformers for Thr302 (labeled A and B).739 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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the A302T mutation. Additionally, the second oxygen atom of
the R-carboxyl group of Ome is further solvated by a water
molecule that is unusually within hydrogen-bonding distance
(2.9 Å) to the thioether sulfur atom of Met344; in contrast, for
Pyl-bound PylRS (PDB ID: 2ZCE), this distance extends to
3.6 Å, which is more consistent with a van der Waals interaction
rather than a more stabilizing hydrogen-bonding interaction.
The R-amino-carboxyl group flip was also seen in the previously
reported crystal structure of PylRS complexed with AMP-PNP
andBoc-Lys(PDBID:2ZIN).Inthislattercase,theAsn346side
chain hydrogen bonds to the R-carboxyl moiety through a water
moleculeinsteadofwiththeR-aminogroupofBoc-Lysasseenin
other wild-type PylRS crystal structures (Figure 5c).
26
The main chain atoms of Pyl sit in a catalytically competent
orientation consistent with the expected in-line nucleophilic
attack of an oxygen atom from the R-carboxyl group on the
R-phosphate atom of AMP-PNP (Figure 6b)
25,27 By contrast, in
MmOmeRS, the R-amino group of Ome sits proximal to the
R-phosphate of AMP-PNP through an intervening network of
water-mediated interactions (Figure 6a). The orientation of the
mainchainatoms inOme isnotuncommonamong structures of
PylRS complexed with various analogues; for example, Boc-Lys
also has its R-amino group close to the R-phosphate of AMP-
PNP (PDB ID: 2ZIN, Figure 6c).
26 These Uaas could readily
rotate the R-carboxyl and R-amino groups along the CR-Cβ
bond to achieve a catalytically competent orientation.
Conclusions. A challenge facing the deployment of tRNA/
RS pairs in mammalian cells is the inability to streamline the
directed evolution of such pairs to produce orthogonal and
catalytically efficient tRNA/RS sets possessing high specificity
for a particular Uaa. The current solution to this bottleneck
consists of evolving E. coli RSs in yeast and transferring the
resultant mutants to mammalian cells.
19,20 The major drawbacks
of using yeast include its lower transformation efficiency and its
restriction to less efficient selection methods compared to those
originally developed in E. coli.
4,16 Unfortunately, M. jannaschii
Figure 5. Structural depiction of interactions between the amino acid
substrate and the surrounding active site residues within MmOmeRS
and PlyRS. (a) Interactions between main chain atoms of the Ome
substrate and surrounding protein residues in the crystal structure of
MmOmeRScomplexedwithOme,Mg
2þ,andAMP-PNP.BothThr302
and Ser399 exist in two rotameric conformations. Dashed lines between
atoms indicate that they are within hydrogen bonding distance. (b)
Interactions between main chain atoms of Pyl and surrounding protein
residuesinthecrystalstructureofPylRScomplexedwithPyl,Mg
2þ,and
AMP-PNP (PDB ID: 2ZCE). (c) Interactions between main chain atoms
of Boc-Lys and surrounding protein residues in the crystal structure of
PylRS complexed with Boc-Lys and AMP-PNP (PDB ID: 2ZIN).
Figure 6. Diﬀerences in coordination geometry between an ATP
analogue and various amino acid substrates in PylRS and MmOmeRS.
(a) Indirect coordination of the Ome amino group to AMP-PNP is
mediated by several waters in the crystal structure of MmOmeRS
complexed with Ome, Mg
2þ, and AMP-PNP. The main chain carboxyl
moiety sits in an orientation that is not directly in-line for attacking the
R-phosphateofAMP-PNP(ATP).(b)Directcoordinationofanoxygen
atomfromthecarboxylgroupofPyltotheR-phosphateofAMP-PNPin
the crystal structure of PylRS complexed with Pyl and AMP-PNP (PDB
ID: 2ZCE). Unlike in the case of MmOmeRS, the main chain carboxyl
group of Pyl resides in an orientation consistent with adenylation. The
red dashed line represents the distance gap between the two atoms that
undergo bond formation during the aminoacylation reaction. (c)
Hydrogen-bonding network of the amino group of Boc-Lys and an
oxygenatomoftheR-phosphateofAMP-PNPinthecrystalstructureof
PylRS complexed with Boc-Lys and AMP-PNP (PDB ID: 2ZIN). This
Uaa sits in an orientation similar to that observed in the MmOmeRS-
Ome-AMP-PNP-Mg
2þ complex.740 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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tRNA
Tyr/TyrRS, which has been extensively evolved in E. coli,
does not act in an orthogonal manner in mammalian cells. On
the other hand, the more recently employed tRNACUA
Pyl /PylRS
pair does have a currently unique property of being orthogonal
in E. coli and mammalian cells, possibly due to its special role
encoding the rarer amino acid Pyl that is not used by E. coli or
mammalian cells. Thus, PylRS mutants evolved in E. coli can
be directly transferred to mammalian cells for efficient Uaa
incorporation.
To date, nearly all Uaas incorporated by evolved PylRS
mutants contain a carbonyl group at the N
ε position of Pyl.
Our report represents a successful breakthrough regarding this
limitation. The chosen amino acid for driving selection, namely,
Ome, does not contain this carbonyl moiety of Pyl, and its side
chain is signiﬁcantly diﬀerent from Pyl and reported Pyl analo-
gues.Anotherstrikingswitchinsynthetasesubstratespeciﬁcityis
the directed evolution of E. coli LeuRS to incorporate a ﬂuor-
escent Uaa dansylalanine.
28 However, the E. coli LeuRS must be
evolved in yeast as it is not orthogonal in E. coli. Although the
previouslyreportedevolutionofPylRStoincorporatePhe-based
Uaas intoproteins inE. coliwas somewhatpromising, incorpora-
tion was achieved in E. coli grown in glycerol minimal media
only.
24 Minimal media is used in published reports to greatly
reduce the mis-incorporation of natural amino acids,
23 raising
concerns with regard to the speciﬁcity of these evolved PylRSs
whenused in rich media, a condition necessary for fermentation,
mammalian cell cultures, and whole organism engineering. Here, the
evolved tRNA/MmOmeRS pair eﬃciently and speciﬁcally incorpo-
rated Ome into proteins both in E. coli using rich media and in
mammalian cells, and we have been able to assign this high level of
speciﬁcity to interactions revealed through structural analysis.
The crystal structure of MmOmeRS reported here illustrates
the stereochemical features governing Uaa recognition at the
molecular level. It was previously thought that the carbonyl
group of the Pyl side chain played a critical role during the
aminoacylation reaction catalyzed by PylRS;
26 Asn346 in wild
typePylRSinteractssimultaneouslywiththissidechaincarbonyl
groupandtheR-aminogroupofPyloraPylanalogue(PDBIDs:
2ZCE, 2ZIN, 2Q7G).
25 27 In contrast, we chose to subject
position 346 to mutational analysis. The resulting mutation
selected at this position, N346V, creates an ideal hydrophobic
pocket for the encapsulation of the Ome phenyl ring. Addition-
ally, the A302T mutation complements the loss of the Asn346
hydrogen bond by forming a network of interactions with the
main chain of the Ome substrate. These surprising observations
indicate that bold yet progressive approaches toward library
design allowed for access to regions of sequence space not
typically explored due to deleterious eﬀects of one mutation,
suggesting that context dependence via compensatory mechan-
isms encouraged the successful evolution of MmOmeRS.
A similar interaction network is observed inseveral other class
II amino acid RSs. For example, in the crystal structure of HisRS
from E. coli (PDB ID: 2EL9), Thr85 (A302T in MmOmeRS) is
within hydrogen-bonding distance of the R-amino group of the
His substrate, while Gly129 (N346V in MmOmeRS) plays no
apparent role in substrate binding. Interestingly, Thr85 is a
conserved residue among all HisRSs, and Gly129 is partial-
ly conserved, indicating that a naturally evolved stabilization
mechanismforsomeRSsiscomparabletothelaboratoryevolved
substrate binding of MmOmeRS reported here. This switch in
the stereochemistry of substrate recognition in MmOmeRS due
to the epistatic nature of two laboratory evolved mutations,
N346V and A302T, has not been reported in any engineered RS
to date. Like the ﬁxed Y384F PylRS mutation that served as a
starting point for this current study, the ﬁxation of the N346V
and A302T mutations may be a necessary step forward for the
designanddirectedevolutionofPylRS-basedmutantsynthetases
that possess an even greater expansion of selectivity for Uaas.
Apart from these two critical positions, a third mutation is
C348W.TheX-raycrystalstructure oftheternary complexagain
demonstrates the stereochemistry of this selected change. The
bulkysidechainindolemoietyofTrp348eﬀectivelyshortensthe
elongated amino acid binding tunnel of wild type PylRS to
accommodate the shorter Ome side chain.
In some synthetases, the tRNA binding event alters the
conformation of the amino acid binding cleft and yields changes
in amino acid substrate binding aﬃnity.
29,30 Although the crystal
structure for the M. mazei tRNA
Pyl/PylRS complex has not been
reported,thecrystalstructure fortheDesulﬁtobacteriumhafniense
tRNA
Pyl/PylRS complex has previously been solved to a resolu-
tion of 3.1 Å.
31 A comparison of this tRNA
Pyl/PylRS complex to
our M. mazei OmeRS structure reveals that the synthetase
components of each structure are very similar; superposition of
CR atoms between the two structures yields an rmsd value of
1.188 Å. The only active site motif that subtly changes con-
formation is the β9 strand where the V401L mutation resides.
However, this subtlety can be accounted for by diﬀerences in
amino acid residues between the two proteins at these positions
and is most likely not relevant to the tRNA binding event
(Supplementary Figure 2). It is of note that the crystal structure
of the tRNA
Pyl/PylRS complex models the β7-β8 loop in a
solventexposedorientation(awayfromtheactivesiteinanopen
position). This loop is absent from the MmOmeRS structure,
and therefore its orientation in a complex with tRNA is un-
predictable. Overall, the absence of the tRNA molecule in the
crystal structure of MmOmeRS most likely does not impact
library design in a directed evolution experiment. However, it is
ofnotethatstructuraldiﬀerencesbetweenaaRSandtRNA/aaRS
complex, if present, should be taken into consideration for
mutant aaRS library design. In addition, rational design of amino
acid speciﬁcity between natural amino acids in an aaRS has been
accomplished and shown torequire many substitutionsthrough-
out the catalytic domain.
38 Therefore, increase of mutant aaRS
library size to target more residues for mutation may further
expand the Uaa diversity and enhance incorporation eﬃciency.
In summary, this study presents the ﬁrst stereochemical
explanation for the laboratory evolved switch in PylRS substrate
speciﬁcity from long aliphatic moieties to shortened aromatic side
chains; this information provides both a molecular and a structural
basis for engineering synthetases with expanded repertoires of Uaas
that can be deployed in an orthogonal manner in complex hosts
such as mammalian cells and multicellular organisms.
’METHODS
PlasmidConstruction. Plasmids were constructed usingstandard
cloningproceduresandconfirmedbyDNAsequencing.ThepTak-GFPtag
plasmid contained the M. mazei tRNACUA
Pyl and the GFP(182TAG) gene
taggedtoaHis6polypeptideappendedtotheC-terminus.Transcriptionof
the tRNACUA
Pyl gene was driven by the lpp promoter and terminated by the
rrnC terminator. GFP(182TAG) gene transcription was driven by the T5
promoter under regulation of the lac operator sequence and transcription
was terminated with the λt0 terminator. Plasmid pTak-Myo4TAG was
created by replacing the GFP(182TAG) gene in pTak-GFPtag with the741 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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sperm whale myoglobin gene containing an amber codon at position 4.
Plasmid pLei-Myo4TAG is identical to pTak- Myo4TAG except the
M. mazei tRNACUA
Pyl was replaced with the M. jannaschii tRNACUA
Tyr , J17.
5
PlasmidpMPcua-OmeRSwas derived frompEYcua-TyrRS
19 byreplacing
the E. coli tRNACUA
Tyr with the M. mazei tRNACUA
Pyl and the E. coli TyrRS
with MmOmeRS. DNA sequences and primers are listed in Supporting
Information.
Library Construction and in Vivo Selection. Three rounds
of overlapping PCRs were performed on the M. mazei PylRS gene to
randomize the codons for each selected active site residue using
oligonucleotides containing NNK at each site destined for mutagenic
diversification. The amplified full-length PCR product was ligated into
the precut pBK5-MmPylRS plasmid to afford the mutant DNA library.
The library was electroporated into DH10βT1 competent cells harbor-
ing pREP-PylT.
10 Selection was carried out on LB plates containing
12.5 μgm L
 1 tetracycline, 50 μgm L
 1 kanamycin, 30 μgm L
 1
chloramphenicol and 1 mM Ome.
Protein Expression and Uaa Incorporation in E. coli. To
translationally incorporate Uaas into myoglobin in E. coli, DH10β cells
were transformed with pTak-Myo4TAG/pBK-MmOmeRS and pLei-
Myo4TAG/pBK-MjOmeRS, respectively. For each sample, a colony
was picked and grown overnight in 50 mL 2xYT supplemented with
30μgmL
 1chloramphenicoland50μgmL
 1kanamycinat37C.This
culture was used to inoculate 1 L of 2xYT containing antibiotics and
supplemented with or without 1 mM of Ome. When OD600 reached
0.5, cells were induced for protein expression by adding 0.5 μM IPTG.
After 3 h, cells were pelleted and sonicated to lyse in 40 mL lysis buffer
(50 mM TrisHCl, pH 8.0, 500 mM NaCl, 20 mM imidazole pH 8.0, 1%
(v/v) Tween 20, 10% (v/v) glycerol, 10 mM 2-mercaptoethanol,
and 0.5 mg mL
 1 lysozyme). Lysed cells were centrifuged for 10 min
at6,000g,andclarifiedsupernatantwaspassedthrougha0.5mLcolumn
of Ni
2þ-NTA agarose resin (Qiagen). The column was washed with
10 column volumes of wash buffer (lysis buffer without Tween 20 and
lysozyme). Protein was eluted with 1 mL of elution buffer (wash buffer
containing250mMimidazolepH8.0).Imidazolewasremovedfromthe
eluentbybufferexchangeusingaMicroconUltracelYM-10spincolumn
(Millipore). The sample was further purified by fast protein liquid
chromatography using a HiLoad 26/60 Superdex 200 gel filtration
column in 50 mM TrisHCl, pH 8.0 with 500 mM NaCl. To incorporate
Ome into GFP, DH10β cells were transformed with pTak-GFPtag and
pBK-MmOmeRS. GFP was purified using the same procedure descri-
bed above.
Protein Expression and Uaa Incorporation in Mammalian
Cells. Uaa incorporation was carried out as previously described.
32
Briefly, HEK293 cells were transfected with pCLHF-GFP(182TAG)
19
and pMPcua-OmeRS. The HeLa-GFP(182TAG) stable cells were
transfected with pMPcua-OmeRS or pEYcua-TyrRS. Cells were grown
inDMEMsupplementedwith10%FBS;1mMofOmewasaddedtoor
withheld from the media for cells transfected with pMPcua-OmeRS.
HEK293 cells were imaged 48 h after transfection with an Olympus
IX8I microscope equipped with a Hamamatsu EM-CCD under same
conditions for all samples (λex =4 8 0( 20 nm, λem =5 3 5( 40 nm).
Transfected HeLa cells were trypsinized and washed with PBS twice.
After resuspending in 1.0 mL PBS and 5 μL of propidium iodide,
cells were analyzed with a FACScan (Becton & Dickinson, excitation
488nm,emission530(30nm).Foreachsamplethetotalfluorescence
intensity of 30,000 cells was recorded and was normalized to cells
transfected with pEYcua-TyrRS, which expresses the E. coli tRNACUA
Tyr /
TyrRS.
19
Mass Spectrometry. For intact protein analysis, myoglobin sam-
ples were analyzed by high resolution Fourier-transform (FT) mass
spectrometry (MS) on a Thermo LTQ-Orbitrap XL mass spectro-
meter
33 (ThermoFisher). Samples were loaded onto a capillary column
with integrated spray tip, which was filled with reversed phase material
(Zorbax SB C-18, particle size 5 μm). Protein was eluted using 0.1%
(v/v) formic acid and a gradient of increasing concentrations of
acetonitrileataflowrateof300nLmin
 1.Theeluatewaselectrosprayed
directly into the mass spectrometer. FT-MS spectra were recorded a
resolution of 60,000 for a scan range of m/z = 400 1800. This was
followedbyaselectionscanofthemostintenseionatresolution60,000.
Data were charge-deconvoluted using the Thermo Qualbrowser 2.0
Xtract program.
ForGFPsamples,∼1μgofproteinwasﬁrstdesaltedusingMicrocon
Ultracel Y-10 spin columns, and then digested with trypsin (200 ng,
Sigma, Proteomics grade) in 50 mM ammonium bicarbonate buﬀer for
16 h. An aliquot of the resulting digest (5 10%) were dried down and
redissolved in 0.1% formic acid. High resolution FT-MS analysis was
performed on a Thermo LTQ-Orbitrap XL. Samples were loaded onto
the same capillary column described above, eluted and electrosprayed
usingthesameprocedures.FT-MSspectrawererecordedataresolution
of 60,000 in the Orbitrap FT analyzer followed by MS/MS scans of the
top 5 ions in the linear ion trap. MS/MS data were searched against a
custom database consisting of the protein of interest using the Mascot
algorithm(Matrixscience).Forthesearch,avariablemodiﬁcationatTyr
residues with a mass of 14.01564 (corresponding to the mass diﬀerence
between Ome and Tyr) was allowed.
Cloning, Expression, and Purification of MmOmeRS. The
C-terminal catalytic domain (residues 185 454) of MmOmeRS was
amplified from the pBK vector containing full length MmOmeRS by
PCR with the following primers: 50-TTC CCA TGG CGC AAG CGC
CCC AGC TCT G-30 and 50-CGC AAG CTT TTA CAG GTT AGT
AGA AAT ACC ATT GTA ATA GGA CTC GG-30. The PCR product
was cloned into an in-house pET28a(þ) vector (Novagen) modified to
contain an N-terminal His8-tag. Both the destination vector and insert
were digested with Nco I and Hind III and ligated using T4 DNA ligase
(New England Biolabs, Inc.). The insert containing plasmid was reco-
vered after initial transformation in E. coli BP5R cells (BioPioneer),
confirmedbyDNAsequencingandtransformedintoE.coliBL21(DE3)
cells (Novagen). One colony was grown at 37 C in TB media to an
OD600of1.0andtheninducedwith1mMIPTGovernightat22C.The
cells were harvested, resuspended in lysis buffer (50 mM HEPES-Na
þ,
pH 7.5, 500 mM NaCl, 20 mM imidazole, 1% (v/v) Tween-20, 10%
(v/v) glycerol, 10 mM 2-mercaptoethanol) containing lysozyme
(0.5 mg mL
 1), and stirred for 45 min at 4 C. The solution was then
sonicated and centrifuged to clarify the supernatant, which was subse-
quently passed through a 1 mL column of Ni-NTA agarose resin
(Qiagen). The column was washed with ten column volumes of lysis
bufferandwashbuffer(lysisbufferwithoutTween20)priortoelutionof
theHis8-taggedMmOmeRSwithelutionbuffer(washbuffercontaining
250 mM imidazole). The eluent was dialyzed overnight in dialysis
buffer (5 mM MgCl2, 300 mM NaCl and 10 mM HEPES-Na
þ, pH 7.5)
and passed through a HiLoad 16/16 Superdex
TM 200 prep grade (GE
Healthcare) gel filtration column. The purified MmOmeRS protein was
concentrated to 10 mg mL
 1 and stored at  80 C.
Crystallization, Structure Solution, and Refinement. Co-
crystallization of MmOmeRS with Ome and AMP-PNP was accom-
plished using a previously described method.
25 Briefly, 1 μL of MmO-
meRS (10 mg mL
 1) containing 5 mM Ome and 5 mM AMP-PNP
was added to 1 μLof reservoir solution (100 mM TrisHCl, pH 8.0, 11%
(w/v) PEG 2000 MME) at 25 C. Crystals were cryostabilized in the
reservoir solution supplemented with 30% (v/v) ethylene glycol and
frozen in liquid nitrogen.
Diﬀraction data were collected on ALS beamline 8.2.2 (Lawrence
Berkeley National Laboratory) using an ADSC Q315 CCD detector.
Images were processed and scaled with XDS.
34 A model of MmOmeRS
was constructed using PylRS as a reference structure, and molecular
replacementfollowedbyroundsofreﬁnementwereperformedusingthe
ccp4programsMolrepandRefmac,respectively.
35TheprogramCOOT742 dx.doi.org/10.1021/cb200057a |ACS Chem. Biol. 2011, 6, 733–743
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wasusedformodelvisualizationandbuildingthroughoutthereﬁnement
process.
36 PROCHECK was used for quality assessment of the ﬁnal
MmOmeRS structure.
37 The data and reﬁnement statistics are pre-
sented in Table 1.
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